Drugs / STEM-OA
STEM-OA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05789719 | Nov 2023 → Nov 2024 | osteoarthritis, knee | StemMedical A/S | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | STEM-OA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05789719 ↗ |
| Known as | alloSTEM-OA | “An Exploratory Clinical Study to Investigate the Effect of autoSTEM-OA and alloSTEM-OA in Participants With Knee Osteoarthritis” NCT05789719 ↗ |
| Known as | autoSTEM-OA | “An Exploratory Clinical Study to Investigate the Effect of autoSTEM-OA and alloSTEM-OA in Participants With Knee Osteoarthritis” NCT05789719 ↗ |
| Modality | Cell therapy | “400x10\^6 autologous MSC(AT)s in autologous fat” NCT05789719 ↗ |